IMA
ImageneBio, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Apr 13 ▼ ImageneBio is raising $30 million through a private placement of pre…
- Apr 13 ▼ ImageneBio (IMA) announced a $30 million private placement led by Co…
- Apr 14 ▲ 2 insiders buy $0.00
- Jul 16 to Jul 17 ▼ 2 days of insider sells: $17.3K by 1 insider, avg $5.42
- Aug 14 ▲ Short interest falls 87.2% to 49.3K
- Aug 21 HC Wainwright & Co. initiates
- Oct 15 ▼ Short interest jumps 86.7% to 61.3K
- Oct 30 ▲ Short interest falls 25.1% to 46.0K
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider sold $17.3K.
- InstitutionsMIXED
Q3 2026: 2 added (0 new), 2 trimmed or exited.
- AnalystsBULLISH
6 of 8 rate it Buy or better. Median target $24.00 (+650%).
- EstimatesRISING
Current-quarter EPS estimate −$1.235 → −$0.847 over 90 days. 2 up, 0 down in 30 days.
- Short sellersCOVERING
Short interest −25.1% to 46.0K shares. 4.0 days to cover, ≈0.4% of shares.
- TrendDOWNTREND
27% below its 50-day average. New closing low $3.20 on Nov 16.
- SocialQUIET
No Reddit mentions this week. Last mention Nov 7.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | ADD | $309.3K |
| VANGUARD FIDUCIARY TRUST CO | ADD | $225.6K |
| MORGAN STANLEY | TRIM | $42.0K |
| CITADEL ADVISORS LLC | TRIM | $328.1K |
| GOLDMAN SACHS GROUP INC | ADD | $91.4K |
| UBS Group AG | ADD | $40.6K |
| JPMORGAN CHASE & CO | NEAR_EXIT | $425.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | ADD | $133.3K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
8 analystsPrice is inside the target range. Median implies +650%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Aug 21, 2026 | HC Wainwright & Co. INITIATE | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Yarema Kristin Chief Executive Officer Aug 14, 2026 | AWARD | 137,200 sh |
Yarema Kristin Chief Executive Officer Aug 14, 2026 | AWARD | 254,800 sh |
Yarema Kristin Chief Executive Officer Aug 14, 2026 | AWARD | 250,000 sh |
Grant-Huerta Yanina Chief Financial Officer Aug 14, 2026 | AWARD | 65,000 sh |
Grant-Huerta Yanina Chief Financial Officer Aug 14, 2026 | AWARD | 39,000 sh |
Grant-Huerta Yanina Chief Financial Officer Aug 14, 2026 | AWARD | 56,000 sh |
Yarema Kristin Chief Executive Officer Jul 25, 2026 | EXERCISE | 38,376 sh |
Yarema Kristin Chief Executive Officer Jul 25, 2026 | OTHER | 115,129 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.85 | -$0.98–-$0.72 | +31.4% | $0.00 |
| Next Q | -$0.91 | -$0.91–-$0.91 | +14.6% | $0.00 |
| Current FY | -$3.37 | -$3.55–-$3.08 | -1.8% | $0.00 |
| Next FY | -$3.36 | -$5.73–-$0.66 | +22.0% | $0.00 |
Short side
FINRA· Oct 30, 2026SecBot reports
7 filings · 3 press releases · 0 bullish · 2 bearish · 5 neutral- NEUTRAL SC 13G/ANov 13, 2026
Blue Owl Capital Holdings LP filed an amended Schedule 13G disclosing beneficial ownership of…
This is a purely administrative correction with no change in stake or intent. Monitor for any future conversion to a 13D if Blue Owl's investment approach shifts, but no immediate action warranted.
- NEUTRAL 8-KNov 9, 2026
ImageneBio reported Q3 2026 net loss of $15.6M ($0.91 per share), narrower than the $24.8M loss…
Monitor the initiation of the Phase 2 alopecia areata study by year-end 2026 and any updates on the ADAPTIVE trial enrollment. The reduced cash burn extends the runway, but the company remains…
- BEARISH EFFECTAug 7, 2026
ImageneBio's registration statement (File No. 333-290108) became effective on August 6, 2026…
Monitor for a prospectus supplement or takedown notice that would specify the size, price, and terms of any offering. The shelf enables the company to raise capital at its discretion, which may…
- NEUTRAL 8-KJun 26, 2026
ImageneBio disclosed the resignation of Robert Lally, SVP of Finance and Operations and principal…
Monitor for the appointment of a new principal accounting officer. The departure is routine and does not signal operational issues, but a prolonged vacancy could raise minor concerns about financial…
All IMA filing & press-release reports (10)
- SC 13G/A reportNov 13, 2026
- 8-K reportNov 9, 2026
- EFFECT reportAug 7, 2026
- 8-K reportJun 26, 2026
- DEFA14A reportApr 30, 2026
- 8-K reportApr 13, 2026
- PRESS-RELEASE reportApr 13, 2026
- EFFECT reportApr 6, 2026
- PRESS-RELEASE reportMar 17, 2026
- PRESS-RELEASE reportMar 10, 2026